William J French
Los Angeles Biomedical Research Institute
United States of America
Dr. French’s is the Director of the Cardiac Catheterization Laboratory, where he has initiated multiple landmark studies, including mixed venous oxygen saturation measurements in obtaining cardiac output, endomyocardial biopsy yield in myocarditis, and studies involving outcomes and treatments in acute myocardial infarction. Additionally, He has been Senior Advisor for the multicenter National Registry of Myocardial Infarction (NRMI) Registry, which trended outcomes in over 2.5 million patients with NSTEMI and STEMI in the United States since 1990.
Dr. French’s research interests include antiplatelet and anticoagulation agents, Interventional Cardiology, statin and diabetic strategies in acute myocardial infarction, and outcomes research in prehospital and EMS care of STEMI heart attack patients.
Fibrinolysis use among patients requiring interhospital transfer for ST-segment elevation myocardial infarction care: a report from the US National Cardiovascular Data Registry. JAMA Intern Med. 2015
Treatment and outcomes of ST segment elevation myocardial infarction and out-of-hospital cardiac arrest in a regionalized system of care based on presence or absence of initial shockable cardiac arrest rhythm. Am J Cardiol. 2014
Current state of ST-segment myocardial infarction: evidence-based therapies and optimal patient outcomes in advanced systems of care. Cardiol Clin. 2014